Rua Bioscience

Rua is a New Zealand cannabis pharmaceutical company that is aiming to be a leading producer of cannabinoid derived medicines. The Company was established in 2017 in part to support local economic development in the Tairawhiti (East Coast) region, and is a pioneer in the New Zealand medicinal cannabis sector. It was the first company in New Zealand to obtain a licence to cultivate cannabis for research purposes. Rua will operate in the research, cultivation, extraction and manufacturing parts of the medicinal cannabis supply chain.

Company Details

Registered Office: 1 Commerce Place, Awapuni, Gisborne 4071

Postal Address: 1 Commerce Place, Awapuni, Gisborne 4071

Telephone: +64-6-390-6938

Facsimile: n/a

Website: www.ruabio.com

First Listed: 22/10/2020

Balance Date: 30 June

AGM: 12/10/2022

Directors and Executives

Tony Barclay

Independent Director

Panapa Ehau

Executive Director

Teresa Farac-Ciprian Independent Non-Executive Director

Brett Gamble

Non-Executive Director

Paul Naske

Chief Executive Officer

Anna Stove

Chair

Hamish White

Chief Financial Officer

Announcements

Title	Date	Type
Issue of shares to employees on conversion of options	Tue, Jun 04 2024 01:22 pm	SECISSUE
Market Insights and Update	Mon, May 20 2024 10:17 am	MKTUPDTE
Rua extends agreement with Nimbus Health	Tue, May 07 2024 03:50 pm	MKTUPDTE
Expansion of Compassionate Access Programme	Mon, Apr 15 2024 09:58 am	MKTUPDTE
Rua partners with AlphaFarma for supply to Germany	Thu, Apr 04 2024 12:55 pm	MKTUPDTE
Rua Bioscience continues Australian expansion	Tue, Apr 02 2024 08:30 am	MKTUPDTE
Cultivation agreement with Cannprisma, Portugal	Tue, Mar 26 2024 01:28 pm	MKTUPDTE
Update: Psilocybe mushrooms cultivation and clinical trials	Mon, Mar 18 2024 01:02 pm	MKTUPDTE
Rua Bioscience Half Year Results	Thu, Feb 29 2024 11:28 am	HALFYR
Rua commences legal proceedings against Cann Group	Thu, Feb 15 2024 11:47 am	GENERAL

Major Holdings Announcements

Date	Name	No. Held	%	Current
22/12/22	Michael John Wilding	8,509,556	-	5.39
18/03/22	Hikurangi Enterprises Limited	8,132,620	-	5.43
17/03/22	Hikurangi Bioactives Limited Partne	4,000,000	12.58	2.67
22/10/20	Tailorspace Capital Limited, Tailor	11,129,375	-	7.95
22/10/20	Fang Group Investment Limited and F	23,584,939	-	16.85
22/10/20	Andrew Charles Williams	7,756,838	-	5.54

Director’s Interests Announcements

Date	Name	No. Held	%	Details	Other
31/05/23	Hamish White	80,895	-	-	-
17/05/23	Antony George Barclay	50,000	-	-	-
02/11/21	Paul Naske	159,872	-	-	-
02/11/21	Rob Mitchell	288,251	-	-	-
02/11/21	Panapa Ehau	474,224	-	-	-
02/11/21	Trevor Burt	958,002	-	-	-
22/10/20	Martin Smith	2,544,732	-	-	-
22/10/20	Brett Gamble	1,805,914	-	-	-
22/10/20	Anna Stove	763,896	-	-	-

Analysts’ Forecasts

No forecasts available

Disclaimer

Data on this page is from BusinessDesk and NZX Ltd for information purposes only. Details are believed to be accurate but no warranty is given as to accuracy, timeliness, reliability or completeness. No person should rely on the contents of the report and all persons should obtain independent professional advice before acting on any information connected with or contained in this report.

Last Updated: 06/06/2023